Dr. El-Aneed is an Associate Professor of Pharmacy. He obtained his B.Sc. (Pharmacy and Pharmaceutical Chemistry) from Tishreen University, Syria, his M.Sc. (Pharmacy) and Ph.D. (Biochemistry) from Memorial University, and an MBA from the UofS. He was awarded the Governor General Gold medal for his Ph.D. thesis. He worked as a pharmacy research specialist at the Newfoundland and Labrador Center for Health Information prior to joining the College in 2008. Dr. El-Aneed’s teaching duties include Physicochemical Principles of Drugsand Analytical Mass Spectrometry.


Dr. El-Aneed’s research focuses on the use of different mass spectrometry platforms for the qualitative and quantitative analysis of small organic compounds, with recent emphasis on diagnostic urine metabolites for lung patients and novel anti-cancer drugs. His team is also developing novel mass spectrometric methods to assess the cellular fate of lipid-based drug delivery systems. He is currently co-chair of the Saskatchewan Mass Spectrometry User Group. In addition to basic science, Dr. El-Aneed is engaged in applied health research, currently investigating the educational needs of community pharmacists regarding substance abuse and addiction.

Recent Publications

  • Khamis M, Adamko D, and El-Aneed A. Mass Spectrometric Based Approaches in Urine Metabolomics and Biomarker Discovery. In Press. Mass Spectrometry Reviews. 2015
  • Michel D, Gaunt M, Arnason T, and El-Aneed A. Development and validation of fast and simple flow injection analysis-tandem mass spectrometry (FIA-MS/MS) for the determination of metformin in dog serum. In press. Journal of Pharmaceutical and Biomedical Analysis. 107, 2015: 229-235.
  • Awad H, Khamis M and El-Aneed A. Mass spectrometry, review of the basics: ionization. Applied Spectroscopy Reviews. 50 (2) 2015: 158-175.
  • Buse J, Purves RW, Verrall RE, Badea I, Zhang H, Mulligan CC, Peru KM, Bailey J, Headley JV, El-Aneed A. The Development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate. Journal of Mass Spectrometry. 49 (11), 2014: 1171-1180.
  • Awad H, Stoudemayer MJ, Usher L, Amster J, Cohen A, Das U, R. Whittal M, Dimmock J, and El-Aneed A.The unexpected formation of [M-H]+ species during MALDI and Dopant free-APPI MS analysis of novel antineoplastic curcumin analogues. Journal of Mass Spectrometry. 49 (11), 2014: 1139-1147.
  • Donkuru M, Chitanda JM, Verrall RE and El-Aneed A. Multi-stage tandem mass spectrometric analysis of novel β-cyclodextrin-substituted and novel bis-pyridinium gemini surfactants designed as nanomedical drug delivery agents. Rapid Communications in Mass Spectrometry. 28 (7), 2014. 28: 757-772.
  • Awad H and El-Aneed A. Enantioselectivity of Mass Spectrometry: Challenges and Promises. Mass Spectrometry Reviews. 32 (6), 2013: 466–483.
  • Lang K, Neil J, Wright J, Dell CA, Berenbaum S, and El-Aneed A. Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers. Substance Abuse Treatment, Prevention, and Policy. 2013. 8 :35 (1 October 2013)
  • Buse J, Badea I, Verrall RE, and El-Aneed A. A general liquid chromatography tandem mass spectrometry method for the quantitative determination of diquaternary ammonium gemini surfactant drug delivery agents in mouse keratinocytes' cellular lysate. Journal of Chromatography A. 1294, 2013: 98–105.
  • Lang K, El-Aneed A, Berenbaum S, Dell CA, Wright J, Teed McKay Z. Qualitative Assessment of Crisis Services among Persons using Injection Drugs in the City of Saskatoon. Journal of Substance Use. 18, (1) 2013: 3-11.